JAGSNPHARM.NS · Jagsonpal Pharmaceuticals Limited
India · RS rating 69 · As of 2026-10-14
| Price | 223.85 INR |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 69 / 49 / 62 / 67 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 38 / 72 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +63.6% |
| Sales growth Q/Q | +28.1% |
| Distance from 52-week high | +8.2% |
| Market cap (USD) | $156.6M |